147 related articles for article (PubMed ID: 26581030)
1. Rapid Clearance of Necrolytic Migratory Erythema Following Intravenous Administration of Amino Acids.
Thomaidou E; Nahmias A; Gilead L; Zlotogorski A; Ramot Y
JAMA Dermatol; 2016 Mar; 152(3):345-6. PubMed ID: 26581030
[No Abstract] [Full Text] [Related]
2. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
[No Abstract] [Full Text] [Related]
3. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
[No Abstract] [Full Text] [Related]
4. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
5. A serpiginous eruption.
Esdaile BA; Hollowood K; Burge S
Arch Dermatol; 2012 Mar; 148(3):385-90. PubMed ID: 22431782
[No Abstract] [Full Text] [Related]
6. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
[No Abstract] [Full Text] [Related]
7. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
[No Abstract] [Full Text] [Related]
8. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
[No Abstract] [Full Text] [Related]
9. Necrolytic migratory erythema and pancreatic glucagonoma.
Rodríguez G; Vargas E; Abaúnza C; Cáceres S
Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical presentation of glucagonoma with delayed onset of necrolytic migratory erythema.
Gaiser CA; Dhawan N
Am J Med; 2015 Feb; 128(2):e1-2. PubMed ID: 25448171
[No Abstract] [Full Text] [Related]
11. Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.
Lo CH; Ho CL; Shih YL
QJM; 2014 Feb; 107(2):157-8. PubMed ID: 23389434
[No Abstract] [Full Text] [Related]
12. Necrolytic migratory erythema: an important sign of glucagonoma.
Cui M; Wang R; Liao Q
Postgrad Med J; 2021 Mar; 97(1145):199. PubMed ID: 32527759
[No Abstract] [Full Text] [Related]
13. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
14. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
15. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
16. Glucagonoma syndrome associated with necrolytic migratory erythema.
Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
[TBL] [Abstract][Full Text] [Related]
17. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
[No Abstract] [Full Text] [Related]
18. Abdominal mass, anemia, diabetes mellitus, and necrolytic migratory erythema.
Qadan M; Visser B; Kim J; Pai R; Triadafilopoulos G
Dig Dis Sci; 2012 Jun; 57(6):1465-8. PubMed ID: 22089253
[No Abstract] [Full Text] [Related]
19. Glucagonoma-related necrolytic migratory erythema.
Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
[No Abstract] [Full Text] [Related]
20. Treatment of necrolytic migratory erythema in glucagonoma syndrome.
Shepherd ME; Raimer SS; Tyring SK; Smith EB
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):925-8. PubMed ID: 1761771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]